These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13540355)

  • 1. [Treatment of 6 cases of pigmentary cirrhosis by blood letting & chelating agents].
    VACHON A; LEHMANN M; DHERS A
    Lyon Med; 1958 Mar; 90(12):457-66. PubMed ID: 13540355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hemochromatosis by chelating agents; report of three cases].
    LANGERON L; PAGET M; CROCCEL L; ROUTIER C
    Ann Biol Clin (Paris); 1958; 16(7-9):524-32. PubMed ID: 13595274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Idiopathic hemochromatosis. Therapeutics].
    Pergola F
    Presse Med (1893); 1967 May; 75(24):1221-2. PubMed ID: 4960744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chelating agents in the treatment of hemochromatosis: comments on a case].
    ALTAVA V; GOMEZ E; PERIS A
    Med Esp; 1959 May; 41(242):401-4. PubMed ID: 13673754
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rapid aggravation of bronze cirrhosis after a therapeutic trial with a chelating (EDTA calcium)].
    MARTY J; LESTAGE J
    Bull Mem Soc Med Hop Paris; 1958 Jan 10-17; 74(1-2):59-60. PubMed ID: 13511175
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemochromatosis with severe arrhythmias. Favourable response under the influence of treatment with disodic calcitetracemate].
    Orjebin P
    Ann Cardiol Angeiol (Paris); 1971; 20(3):253-60. PubMed ID: 4997674
    [No Abstract]   [Full Text] [Related]  

  • 7. [First reports of treatment of bronzed diabetes with chelating agents].
    LANGERON L; PAGET M; ROUTIER G
    Bull Mem Soc Med Hop Paris; 1956; 72(27-28):911-5. PubMed ID: 13396597
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemochromatosis in a castrate; treatment by a calcic chelating agent].
    VALLAT JN; TEXIER J; LAURES JC; DELUCHAT J; FAUCHER G
    Presse Med (1893); 1957 Dec; 65(95):2223 passim. PubMed ID: 13505720
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary cancer of the liver with cirrhosis & hemochromatosis: adenocancer of the liver with pigmentary cirrhosis].
    GUICHARD A; TOMMASI M
    J Med Lyon; 1958 May; 39(920):377-91. PubMed ID: 13549926
    [No Abstract]   [Full Text] [Related]  

  • 10. [Employment of chelating agents of the Calcium E.D.T.A. type during the course of various excessive blood iron conditions].
    LAMACHE A; BOUREL M; VIVIEN P; CORMIER M; LENOIR P; AZARD C; DELAHAYE D
    Sem Med Prof Med Soc; 1957 Feb; 33(7):295-8. PubMed ID: 13421822
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rapid aggravation of 2 cases of pigmentary cirrhosis after trial therapy with a chelator, EDTA calcium].
    KLOTZ HP; AVRIL J; PARIENTE R
    Bull Mem Soc Med Hop Paris; 1957 Nov 15-22; 73(29-30):1001-3. PubMed ID: 13500185
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood and urine iron changes in a case of hemochromatosis treated with calcium and sodium ethylenediaminetetraacetate].
    MERVILLE R; DEQUIDT J; TACQUET A; LUEZ J; CORTEEL ML
    Arch Mal Appar Dig Mal Nutr; 1958 Jun; 47(6):751-7. PubMed ID: 13560095
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chelating agents in the therapy of hemochromatosis. Comments on a case after one year of treatment].
    ALTAVA V; GOMEZ E
    Med Esp; 1960 Aug; 44():122-4. PubMed ID: 13682709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of monocalcium-disodium-ethylenediaminetetraacetic acid on renal iron excretion in two cases of iron accumulation].
    SCHLEPPER M; TOLLE KH
    Arztl Forsch; 1957 Dec; 11(12):I/589-90. PubMed ID: 13497870
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chelating agents in hemochromatosis; therapeutic method or diagnostic test].
    WATER J; WEILL JP
    Presse Med (1893); 1957 Aug; 65(60):1371-3. PubMed ID: 13477735
    [No Abstract]   [Full Text] [Related]  

  • 16. The liver in celiac disease.
    Rubio-Tapia A; Murray JA
    Hepatology; 2007 Nov; 46(5):1650-8. PubMed ID: 17969053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is exchange transfusion a possible treatment for neonatal hemochromatosis?
    Timpani G; Foti F; Nicolò A; Nicotina PA; Nicastro E; Iorio R
    J Hepatol; 2007 Nov; 47(5):732-5. PubMed ID: 17869371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chelating agents in dermatology; first trials].
    THIERS H; COLOMB D; PATET R; THEVENON J
    Bull Soc Fr Dermatol Syphiligr; 1957; 64(1):60-1. PubMed ID: 13437024
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemochromatosis & melanodermic porphyria as various forms of blood formation disorder in pigmentary cirrhosis & bronze diabetes].
    BRUGSCH J
    Z Gesamte Inn Med; 1958 Jun; 13(12):411-5. PubMed ID: 13581872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chelating agents during hypersiderinemia].
    LAMACHE A; BOUREL M; CORMIER ; LENOIR P; AZARD C; DELAHAYE D
    Bull Acad Natl Med; 1957 Feb 19-26; 141(7-8):137-43. PubMed ID: 13413354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.